Filing Details

Accession Number:
0001209191-21-066134
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-22 17:05:01
Reporting Period:
2021-11-19
Accepted Time:
2021-11-22 17:05:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1445499 Impel Neuropharma Inc IMPL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1244229 S Timothy Nelson C/O Impel Neuropharma, Inc.
201 Elliott Ave. W, St. 260
Seattle WA 98119
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-19 10,000 $10.76 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.71 to $10.85 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.